Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury

Transplantation

Volumn 96, Issue 10, 2013, Pages 863-870

  Kono, Hidaka ^a   Nakagawa, Ken ^a   Morita, Shinya ^a   Shinoda, Kazunobu ^a   Mizuno, Ryuichi ^a   Kikuchi, Eiji ^a   Miyajima, Akira ^a   Umezawa, Kazuo ^b   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Nuclear factor kB; Renal ischemia reperfusion injury; Tubular necrosis

Indexed keywords

CREATININE; CYTOKINE; DEHYDROXYMETHYLEPOXYQUINOMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ARTERY CLAMP; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL ARTERY; REPERFUSION INJURY; URINE VOLUME;

ANIMALS; DELAYED GRAFT FUNCTION; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; I-KAPPA B PROTEINS; KIDNEY TRANSPLANTATION; RATS; RATS, INBRED LEW; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 84891832773     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a3df74     Document Type: Article

References (31)

1. Donnahoo KK, Meldrum DR, Shenkar R, et al. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNFalpha bioactivity in the kidney. J Urol 2000; 163: 1328.
2. Koo DD, Welsh KI, Roake JA, et al. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557.
3. Burns AT, Davies DR, McLaren AJ, et al. Apoptosis in ischemia/ reperfusion injury of human renal allografts. Transplantation 1998; 66: 872.
4. Matas AJ. Chronic rejectionVdefinition and correlates. Clin Transplant 1994; 8: 162.
5. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
6. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
7. Vazquez MA. Chronic rejection of renal transplants: new clinical insights. Am J Med Sci 2000; 320: 43.
8. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
9. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697.
10. Umezawa K, Chaicharoenpong C. Molecular design and biological activities of NF-kappaB inhibitors. Mol Cells 2002; 14: 163.
11. Matsumoto N, Ariga A, To-e S, et al. Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C. Bioorg Med Chem Lett 2000; 10: 865.
12. Azuma H, Nadeau K, Takada M, et al. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997; 64: 190.
13. Meldrum KK, Hile K, Meldrum DR, et al. Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol 2002; 168: 248.
14. Ishibashi N, Weisbrot-Lefkowitz M, Reuhl K, et al. Modulation of chemokine expression during ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J Immunol 1999; 163: 5666.
15. Cao CC, Ding XQ, Ou ZL, et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 2004; 65: 834.
16. Takuma K, Lee E, Kidawara M, et al. Apoptosis in Ca2+ reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NFkappaB activation. Eur J Neurosci 1999; 11: 4204.
17. Matsushita H,Morishita R, Nata T, et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 2000; 86: 974.
18. Wong JH, Lui VW, Umezawa K, et al. A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett 2010; 287: 23.
19. Kodaira K, Kikuchi E, Kosugi M, et al. Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. Urology 2010; 75: 805.
20. Dabaghmanesh N, Matsubara A, Miyake A, et al. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation. Cancer Sci 2009; 100: 737.
21. Lampiasi N, Azzolina A, D'Alessandro N, et al. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaBinhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol Pharmacol 2009; 76: 290.
22. Nishimura A, Akeda K, Matsubara T, et al. Transfection of NF-kappaB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma. Cancer Gene Ther 2011; 18: 250.
23. Land W, Messmer K, Events E. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Transplant Rev 1996; 10: 108.
24. Nakagawa K, Koo DD, Davies DR, et al. Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction. Kidney Int 2002; 61: 1160.
25. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64: 945.
26. Land WMD. Reactive oxygen species in chronic allograft dysfunction. Curr Opin Organ Transplant 1999; 4: 16.
27. Chandraker A, Takada M, Nadeau KC, et al. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 1997; 52: 1678.
28. Takada M, Nadeau KC, Shaw GD, et al. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 1997; 64: 1520.
29. Tsuda H, Kawada N, Kaimori JY, et al. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun 2012; 427: 266.
30. De Miguel C, Das S, Lund H, et al. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1136.
31. De Miguel C, Guo C, Lund H, et al. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. AmJ Physiol Renal Physiol 2011; 300: F734.